If you have type 2 diabetes and need help controlling post‑meal spikes, you’ve probably heard of repaglinide. It’s an oral tablet that tells your pancreas to release a quick burst of insulin right after you eat. Unlike long‑acting drugs, repaglinide works fast and fades within a few hours, so it’s good for people who have irregular meal times.
When you start repaglinide, your doctor will give you a dose based on your current blood‑sugar numbers and what you eat. The usual starting dose is 0.5 mg taken 15‑30 minutes before each meal. If you skip a meal, you skip the dose—no need to take it later.
Here are three easy steps to make sure you get the most out of the pill:
Most people see a noticeable drop in their 2‑hour post‑meal glucose within a week. If the numbers don’t improve, talk to your doctor about adjusting the dose.
Like any medication, repaglinide has side effects. The most common are mild stomach upset, headache, and occasional dizziness. A rarer, but serious, issue is low blood sugar (hypoglycemia). You’ll know you’re low if you feel shaky, sweaty, or confused. Keep a quick source of sugar—like glucose tablets or fruit juice—on hand.
Other red flags include:
Never mix repaglinide with other insulin‑boosting drugs without medical guidance. Alcohol can also increase hypoglycemia risk, especially if you drink on an empty stomach.
Many people look for cheaper options online. If you decide to buy repaglinide off the internet, follow these safety steps:
When the package arrives, inspect the labeling, expiration date, and packaging integrity. If anything looks off, contact the pharmacy before using the pills.
Bottom line: repaglinide can be a handy tool for managing post‑meal blood sugar, as long as you time it right, watch for low‑sugar symptoms, and buy from a reputable source. Talk to your healthcare provider if you have any doubts—your safety is worth the extra effort.
Everything you need to know about Glyset - how it works, proper dosing, common side effects, drug interactions and current pricing in Australia.
September 21 2025